Data and Research Manager
Barbara is a Data and Research Manager in the International Severe Acute Respiratory and Emerging Infections Consortium (ISARIC), at the University of Oxford. Barbara manages a large clinical database of over 900,000 hospitalised COVID-19 patients, leads and contributes to analyses using these data, and coordinates international research collaborations among investigators in over 60 countries.
Prior to joining ISARIC, Barbara worked in infectious diseases research, and as a scientist in vaccine and drug development.
Major adverse cardiovascular events (MACE) in patients with severe COVID-19 registered in the ISARIC WHO clinical characterization protocol: A prospective, multinational, observational study.
Reyes LF. et al, (2023), Journal of critical care, 77
Thrombotic and hemorrhagic complications of COVID-19 in adults hospitalized in high-income countries compared with those in adults hospitalized in low- and middle-income countries in an international registry.
Griffee MJ. et al, (2023), Research and practice in thrombosis and haemostasis, 7
Association of Country Income Level With the Characteristics and Outcomes of Critically Ill Patients Hospitalized With Acute Kidney Injury and COVID-19.
Wainstein M. et al, (2023), Kidney international reports
Characteristics and outcomes of an international cohort of 600 000 hospitalized patients with COVID-19
Kartsonaki C. et al, (2023), International Journal of Epidemiology, 52, 355 - 376
Neurological manifestations of COVID-19 in adults and children.
Cho S-M. et al, (2023), Brain : a journal of neurology, 146, 1648 - 1661